View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Understanding Cold Agglutinin Disease: How Do Emerging Treatment Options Have the Potential to Transform Patient Outcomes?

Understanding Cold Agglutinin Disease: How Do Emerging Treatment Options Have the Potential to Transform Patient Outcomes?

Friday, December 4, 2020

Live, Interactive Virtual Webcast!

7:00 AM – 9:00 AM PST


Cold agglutinin disease (CAD) is a serious condition with unpredictable anemia events ranging in occurrence and severity, and which can be debilitating and potentially life-threatening. More than half of patients may require transfusions, and a large majority need treatment; but options are limited, and none are specifically approved for CAD. However, novel complement-directed therapies are in development that hold promise for this autoimmune hemolytic anemia.

A panel of experts in CAD will first review the disease types and their impact on patient’s lives, and then discuss the pathophysiologic role of complement and the mechanisms involved in acute exacerbations of hemolytic anemia. Patient cases will be used to demonstrate accurate diagnosis and current treatment options. Updates on clinical trials for emerging agents will be presented with commentary from the faculty.

Benefits of Attending

This activity will better prepare you to:

  • Understand the typical and atypical signs, symptoms, and triggers for CAD
  • Gain insights on making an accurate diagnosis of CAD for appropriate treatment
  • Evaluate emerging complement-modulating treatment options
  • Network with leading faculty experts

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Target Audience

This educational activity is directed toward medical hematologists and other health care professionals interested in the latest advances in the treatment of patients with CAD. Fellows, researchers, primary care physicians, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the treatment of patients with hematologic diseases are also invited to participate.

Learning Objectives

Upon completion of this activity, you will be able to:

  • Discuss risks associated with CAD, as well as disease-related patient impact
  • Explain the role of the complement system, which leads to recognition of CAD as a distinct clinical entity
  • Identify typical and atypical clinical manifestations of CAD and apply effective disease-specific assessments
  • Describe the role of complement-mediated therapies based on current efficacy and safety data of new and emerging agents for the treatment of patients with CAD

Program Chair

Alexander Röth, MD
Alexander Röth, MD
Physician, Department of Hematology
West German Cancer Center
University Hospital Essen
Essen, Germany


3 Ways to Register

  1. Online: Click here for online registration.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701 (credit card required).
  3. Fax: (609) 257-0705 (credit card required).

Physicians’ Education Resource, LLC (PER®)
2 Clarke Drive
Suite 110
Cranbury, NJ 08512

Physicians' Education Resource®, LLC (PER®), fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.

By attending a PER® conference, meeting, or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By